Table 3.

Univariate Cox Proportional Hazard models of development of HTN during 9-year follow-up

Variables	HR(95%CI)	P value
Gender (male)	1.61(1.46–1.78)	<  0.001
Age (years)	1.03(1.03–1.04)	<  0.001
BMI (kg/m2)	1.16(1.15–1.18)	<  0.001
WC (cm)	1.06(1.05–1.06)	<  0.001
BUN (mmol/L)	1.11(1.07–1.15)	<  0.001
Cr (μmol/L)	1.00(1.00–1.01)	<  0.001
FPG (mmol/L)	1.26(1.21–1.30)	<  0.001
UA (μmol/L)	1.00(1.00–1.00)	<  0.001
AST (U/L)	1.01(1.00–1.01)	<  0.001
ALT (U/L)	1.00(1.00–1.00)	<  0.001
y-GGT (U/L)	1.00(1.00–1.01)	<  0.001
TC (mmol/L)	1.28(1.22–1.34)	<  0.001
TG (mmol/L)	1.29(1.25–1.33)	<  0.001
HDL-C (mmol/L)	0.86(0.77–0.97)	0.010
LDL-C (mmol/L)	1.31(1.24–1.38)	<  0.001
Apo-A1 (g/L)	1.02(0.86–1.21)	0.812
Apo-B (g/L)	3.47(2.95–4.09)	<  0.001
eGFR (mL/(min·1.73 m2))	1.00(0.99–1.00)	<  0.001
FLI categories		<  0.001
<  30	1.00(reference)
30–59	2.17(1.97–2.40)
≥ 60	3.00(2.61–3.46)